Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Parisio

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel diseaseTommaso Innocenti, Jenny Roselli, Erica N Lynch, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical RemissionLaura Parisio, Carlo Romano Settanni, Simone Varca, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|January 20, 2024
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patientsDaniele Napolitano, Carlo Romano Settanni, Laura Parisio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2026
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net studyAngelo Del Gaudio, Emma Calabrese, Paola Balestrieri, et al.
Journal of Clinical Medicine|September 13, 2025
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective StudyLaura Parisio, Angelo Del Gaudio, Jacopo Iaccarino, et al.
Biomedicines|April 23, 2022
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control StudyAlfredo Papa, Franco Scaldaferri, Marcello Covino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 20, 2023
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD studyDavide Giuseppe Ribaldone, Laura Parisio, Angela Variola, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel diseaseTommaso Innocenti, Jenny Roselli, Erica N Lynch, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical RemissionLaura Parisio, Carlo Romano Settanni, Simone Varca, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|January 20, 2024
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patientsDaniele Napolitano, Carlo Romano Settanni, Laura Parisio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2026
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net studyAngelo Del Gaudio, Emma Calabrese, Paola Balestrieri, et al.
Journal of Clinical Medicine|September 13, 2025
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective StudyLaura Parisio, Angelo Del Gaudio, Jacopo Iaccarino, et al.
Biomedicines|April 23, 2022
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control StudyAlfredo Papa, Franco Scaldaferri, Marcello Covino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 20, 2023
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD studyDavide Giuseppe Ribaldone, Laura Parisio, Angela Variola, et al.
Pageof 2